Isabella Glitza Oliva

33PUBLICATIONS
241CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyNanomedicineMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Apr 21, 2026
Intratumoral sotigalimab with pembrolizumab induces rapid activation of antigen presenting cells and drives anti-tumor responses in non-injected tumors in metastatic melanoma: A phase I/II study.

|Jan 10, 2026
Investigating Chronic Toxicity, Diet, Patient-Reported Outcomes and the Microbiome in Immunotherapy-Treated Metastatic Melanoma Survivors: A New Frontier.

Margaux Robert, Satabdi Saha, Nazli Dizman

|Nov 27, 2025
Primary Intramedullary Spinal Melanocytomas: Case Report and Review of Clinical Features, Diagnosis, and Management.

Gil Kimchi, Samantha Varela, Juan Pablo Zuluaga-Garcia

|Jul 10, 2025
Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma.

Elizabeth M Burton, Denái R Milton, Michael T Tetzlaff

|Mar 07, 2025
Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols.

Tricia R Cottrell, Michael T Lotze, Alaa Ali

|Jan 31, 2025
Real-world outcomes in patients with melanoma brain metastasis: a US multisite retrospective chart review study of systemic treatments.

Isabella C Glitza Oliva, Jennell Palaia, Leon A Sakkal

Pageof 6

Frequent Collaborators

15 joint publications

Michael A Davies

12 joint publications

Hussein Tawbi

10 joint publications

Sapna Patel

8 joint publications

Jennifer A Wargo